Celanese Corporation (CE)

$155.78

-0.26

(-0.17%)

Market is closed - opens 7 PM, 16 Apr 2024

Insights on Celanese Corporation

  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 2.85B → 2.56B (in $), with an average decrease of 3.4% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 951.0M → 698.0M (in $), with an average decrease of 26.6% per quarter

Performance

  • $154.36
    $158.15
    $155.78
    downward going graph

    0.91%

    Downside

    Day's Volatility :2.4%

    Upside

    1.5%

    downward going graph
  • $97.32
    $172.16
    $155.78
    downward going graph

    37.53%

    Downside

    52 Weeks Volatility :43.47%

    Upside

    9.51%

    downward going graph

Returns

PeriodCelanese CorporationSector (Materials)S&P500
3 Months
7.94%
9.0%
7.5%
6 Months
29.55%
14.7%
17.1%
1 Year
41.07%
11.1%
23.8%
3 Years
-1.19%
8.8%
22.4%

Highlights

Market Capitalization
17.4B
Book Value
$65.11
Dividend Share
2.8
Dividend Yield
1.79%
Earnings Per Share (EPS)
18.01
PE Ratio
8.66
PEG Ratio
4.42
Wall Street Target Price
161.0
Profit Margin
17.92%
Operating Margin TTM
7.86%
Return On Assets TTM
2.72%
Return On Equity TTM
28.89%
Revenue TTM
10.9B
Revenue Per Share TTM
100.51
Quarterly Revenue Growth YOY
9.4%
Gross Profit TTM
2.4B
EBITDA
1.8B
Diluted Eps TTM
18.01
Quarterly Earnings Growth YOY
-0.09
EPS Estimate Current Year
11.4
EPS Estimate Next Year
13.91
EPS Estimate Current Quarter
2.31
EPS Estimate Next Quarter
2.53

Analyst Recommendation

Buy
    50%Buy
    43%Hold
    6%Sell
Based on 30 Wall street analysts offering stock ratings for Celanese Corporation(by analysts ranked 0 to 5 stars)
Based on 30 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
15
15
15
Hold
13
13
16
Sell
2
2
1

Analyst Forecast

What analysts predicted

Upside of 3.35%

Current $155.78
Target $161.00

Company Financials

FY18Y/Y Change
Revenue
7.2B
↑ 16.53%
Net Income
1.2B
↑ 43.18%
Net Profit Margin
16.87%
↑ 3.14%
FY19Y/Y Change
Revenue
6.3B
↓ 11.99%
Net Income
852.0M
↓ 29.41%
Net Profit Margin
13.53%
↓ 3.34%
FY20Y/Y Change
Revenue
5.7B
↓ 10.2%
Net Income
2.0B
↑ 132.98%
Net Profit Margin
35.1%
↑ 21.57%
FY21Y/Y Change
Revenue
8.5B
↑ 50.96%
Net Income
1.9B
↓ 4.79%
Net Profit Margin
22.14%
↓ 12.96%
FY22Y/Y Change
Revenue
9.7B
↑ 13.31%
Net Income
1.9B
↑ 0.21%
Net Profit Margin
19.58%
↓ 2.56%
FY23Y/Y Change
Revenue
10.9B
↑ 13.1%
Net Income
2.0B
↑ 3.48%
Net Profit Margin
17.92%
↓ 1.66%
Q3 FY22Q/Q Change
Revenue
2.3B
↓ 7.44%
Net Income
191.0M
↓ 55.99%
Net Profit Margin
8.3%
↓ 9.16%
Q4 FY22Q/Q Change
Revenue
2.3B
↑ 2.04%
Net Income
767.0M
↑ 301.57%
Net Profit Margin
32.67%
↑ 24.37%
Q1 FY23Q/Q Change
Revenue
2.9B
↑ 21.51%
Net Income
91.0M
↓ 88.14%
Net Profit Margin
3.19%
↓ 29.48%
Q2 FY23Q/Q Change
Revenue
2.8B
↓ 2.03%
Net Income
220.0M
↑ 141.76%
Net Profit Margin
7.87%
↑ 4.68%
Q3 FY23Q/Q Change
Revenue
2.7B
↓ 2.58%
Net Income
951.0M
↑ 332.27%
Net Profit Margin
34.92%
↑ 27.05%
Q4 FY23Q/Q Change
Revenue
2.6B
↓ 5.66%
Net Income
698.0M
↓ 26.6%
Net Profit Margin
27.17%
↓ 7.75%
FY18Y/Y Change
Total Assets
9.3B
↓ 2.36%
Total Liabilities
5.9B
↓ 4.89%
FY19Y/Y Change
Total Assets
9.5B
↑ 1.75%
Total Liabilities
6.6B
↑ 10.85%
FY20Y/Y Change
Total Assets
10.9B
↑ 15.12%
Total Liabilities
7.0B
↑ 6.63%
FY21Y/Y Change
Total Assets
12.0B
↑ 9.77%
Total Liabilities
7.4B
↑ 6.05%
FY22Y/Y Change
Total Assets
26.3B
↑ 119.39%
Total Liabilities
20.2B
↑ 171.13%
FY23Y/Y Change
Total Assets
26.6B
↑ 1.24%
Total Liabilities
19.0B
↓ 5.56%
Q3 FY22Q/Q Change
Total Assets
21.3B
↑ 67.84%
Total Liabilities
16.0B
↑ 114.25%
Q4 FY22Q/Q Change
Total Assets
26.3B
↑ 23.13%
Total Liabilities
20.2B
↑ 25.71%
Q1 FY23Q/Q Change
Total Assets
26.1B
↓ 0.69%
Total Liabilities
20.0B
↓ 1.03%
Q2 FY23Q/Q Change
Total Assets
25.6B
↓ 1.69%
Total Liabilities
19.6B
↓ 2.0%
Q3 FY23Q/Q Change
Total Assets
25.5B
↓ 0.43%
Total Liabilities
18.6B
↓ 4.97%
Q4 FY23Q/Q Change
Total Assets
26.6B
↑ 4.15%
Total Liabilities
19.0B
↑ 2.45%
FY18Y/Y Change
Operating Cash Flow
1.6B
↑ 94.02%
Investing Cash Flow
-507.0M
↓ 7.65%
Financing Cash Flow
-1.2B
↑ 231.91%
FY19Y/Y Change
Operating Cash Flow
1.5B
↓ 6.68%
Investing Cash Flow
-493.0M
↓ 2.76%
Financing Cash Flow
-935.0M
↓ 19.74%
FY20Y/Y Change
Operating Cash Flow
850.0M
↓ 41.54%
Investing Cash Flow
592.0M
↓ 220.08%
Financing Cash Flow
-1.5B
↑ 57.33%
FY21Y/Y Change
Operating Cash Flow
1.8B
↑ 106.71%
Investing Cash Flow
-1.1B
↓ 289.02%
Financing Cash Flow
-1.0B
↓ 29.16%
FY22Y/Y Change
Operating Cash Flow
1.8B
↑ 3.53%
Investing Cash Flow
-11.1B
↑ 895.62%
Financing Cash Flow
10.3B
↓ 1087.52%
Q3 FY22Q/Q Change
Operating Cash Flow
467.0M
↓ 5.66%
Investing Cash Flow
-143.0M
↑ 5.15%
Financing Cash Flow
8.6B
↓ 5508.81%
Q4 FY22Q/Q Change
Operating Cash Flow
541.0M
↑ 15.85%
Investing Cash Flow
-10.7B
↑ 7391.61%
Financing Cash Flow
1.9B
↓ 77.4%
Q1 FY23Q/Q Change
Operating Cash Flow
-96.0M
↓ 117.74%
Investing Cash Flow
-178.0M
↓ 98.34%
Financing Cash Flow
-69.0M
↓ 103.55%
Q2 FY23Q/Q Change
Operating Cash Flow
762.0M
↓ 893.75%
Investing Cash Flow
-163.0M
↓ 8.43%
Financing Cash Flow
-447.0M
↑ 547.83%
Q3 FY23Q/Q Change
Operating Cash Flow
403.0M
↓ 47.11%
Investing Cash Flow
34.0M
↓ 120.86%
Financing Cash Flow
-700.0M
↑ 56.6%

Technicals Summary

Sell

Neutral

Buy

Celanese Corporation is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Celanese Corporation
Celanese Corporation
-3.86%
29.55%
41.07%
-1.19%
48.09%
Braskem S.a.
Braskem S.a.
8.68%
24.6%
11.42%
-46.66%
-63.1%
Dow Inc.
Dow Inc.
1.67%
14.94%
1.39%
-10.81%
-1.38%
Huntsman Corporation
Huntsman Corporation
-4.74%
3.26%
-12.11%
-16.85%
-1.71%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Celanese Corporation
Celanese Corporation
8.66
8.66
4.42
11.4
0.29
0.03
0.02
65.11
Braskem S.a.
Braskem S.a.
26.15
NA
-1.31
-0.99
-1.04
0.0
NA
5.01
Dow Inc.
Dow Inc.
70.35
70.35
0.78
3.02
0.03
0.03
0.05
26.5
Huntsman Corporation
Huntsman Corporation
46.54
NA
1.79
0.56
0.01
0.01
0.04
18.95
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Celanese Corporation
Celanese Corporation
Buy
$17.4B
48.09%
8.66
17.92%
Braskem S.a.
Braskem S.a.
Buy
$3.8B
-63.1%
26.15
-6.49%
Dow Inc.
Dow Inc.
Hold
$40.8B
-1.38%
70.35
1.32%
Huntsman Corporation
Huntsman Corporation
Hold
$4.2B
-1.71%
46.54
1.65%

Institutional Holdings

  • Capital Research Global Investors

    13.27%
  • Vanguard Group Inc

    11.72%
  • Capital Research & Mgmt Co - Division 3

    10.16%
  • Wellington Management Company LLP

    7.65%
  • Dodge & Cox

    6.14%
  • BlackRock Inc

    5.98%

Corporate Announcements

  • Celanese Corporation Dividends March,2024

    In the quarter ending March,2024. Celanese Corporation has declared dividend of $0.7

    Read More

Company Information

who is celanese? we’re engineers, scientists, operators and product developers. we’re innovators, advisers, designers and problem solvers. most importantly, we’re partners – in creating value for our customers with the solutions we offer and in improving the world through the actions of our colleagues. celanese is the chemistry inside innovation™ and we aspire to be the first-choice chemistry solution source for our customers. we know what you’re thinking – that’s a lot to promise and that’s a lot to do. well, we would agree with you, but we’re up for the challenge and we owe it to our customers, shareholders, and employees to deliver on our promise. what does celanese do? we produce products that make our lives a little easier, by helping customers to bring their inspired ideas and innovations to life. from the global production network of our acetyl chain, we provide materials that are critical to the global chemicals and paints and coatings industries. from our broad portfol

Organization
Celanese Corporation
Employees
12410
CEO
Ms. Lori J. Ryerkerk BS
Industry
Process Industries

FAQs